Insights into E-Cadherin Impairment in CDH1-Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic Study
Open Access
- 17 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8961
Abstract
Invasive lobular carcinoma exhibits unique morphological features frequently associated with alterations in CDH1. Although some studies have identified abnormalities in adhesion factors other than E-cadherin, the molecular mechanisms underlying E-cadherin abnormalities in CDH1-unaltered invasive lobular carcinoma remain poorly understood. In this study, we investigated the molecular underpinnings of E-cadherin dysregulation in invasive lobular carcinoma in the absence of CDH1 gene alterations, using comprehensive bioinformatic analyses. We conducted a comparative study of CDH1-mutated and non-mutated invasive lobular carcinoma and evaluated the differences in mRNA levels, reverse-phase protein array, methylation, and miRNAs. We observed that invasive lobular carcinoma cases without CDH1 alterations exhibited a significantly higher incidence of the Claudin-low subtype (p < 0.01). The results of the reverse-phase protein array indicate no significant difference in E-cadherin expression between CDH1-mutated and non-mutated cases. Therefore, abnormalities in E-cadherin production also exist in CDH1 non-mutated invasive lobular carcinoma. Considering that there are no differences in mRNA levels and methylation status, post-translational modifications are the most plausible explanation for the same. Hence, future studies should focus on elucidating the mechanism underlying E-cadherin inactivation via post-translational modifications in CDH1 non-mutated invasive lobular carcinoma.Keywords
This publication has 38 references indexed in Scilit:
- Prevalence and mutational determinants of high tumor mutation burden in breast cancerAnnals of Oncology, 2020
- αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancerThe Journal of Pathology, 2018
- Comprehensive Molecular Portraits of Invasive Lobular Breast CancerCell, 2015
- E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and VBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Modulation of E-cadherin function and dysfunction by N-glycosylationCellular and Molecular Life Sciences, 2010
- Epigenetic silencing in non‐neoplastic epithelia identifies E‐cadherin (CDH1) as a target for chemoprevention of lobular neoplasiaThe Journal of Pathology, 2009
- The cell-cell adhesion molecule E-cadherinCellular and Molecular Life Sciences, 2008
- Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERADGlycoconjugate Journal, 2008
- Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomasVirchows Archiv, 1997
- E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.The EMBO Journal, 1995